As we continue to lay the groundwork in support of an over-the-counter (OTC) combined oral contraceptive (COC), it is critical to leverage new and existing research to inform policy and advocacy strategies and ensure equitable access. This panel discussion provides an overview of key research on COCs, including screening for contraindications, the prevalence of contraindications among potential users, hypertension-related risks, and the public health benefits of OTC access.
The evidence on and experiences with combined oral contraceptives: Opportunities, challenges, and key considerations for an OTC COC
Next
Next